CPEX: Summary for CPEX Pharmaceuticals, Inc. - Yahoo! Canada Finance

	Sign In [New User? Sign Up]	Finance Home \|Help

Wednesday, February 10, 2010, 8:29am EST - Canadian Markets open in 1 hour and 1 minute.

To create a watchlist or portfolio of shares, Sign-in or Register

CPEX Pharmaceuticals, Inc. (CPEX)

On Feb 9: 16.67 USD 0.00 (0.00%)

MORE ON CPEX

Quotes

Summary

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

CPEX Pharmaceuticals, Inc. (NCM:CPEX) Delayed quote data

Last Trade:	16.67 USD
Trade Time:	Feb 9
Change:	0.00 (0.00%)
Prev Close:	16.67
Open:	N/A
Bid:	13.80 x 100
Ask:	20.20 x 100
1y Target Est:	N/A

Day's Range:	N/A - N/A
52wk Range:	6.15 - 16.67
Volume:	0
Avg Vol (3m):	10,384.1
Market Cap:	42.38M
P/E (ttm):	N/A
EPS (ttm):	-0.90
Div & Yield:	N/A (N/A%)

1d 5d 3m 6m 1y 2y

Add CPEX to Portfolio

Download Data

HEADLINES

•	CPEX PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers
	EDGAR Online (Wed, Feb 3)

•	CPEX PHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure
	EDGAR Online (Tue, Feb 2)

•	CPEX Pharmaceuticals Announces Appointment of New Chief Scientific Officer
	Business Wire (Mon, Feb 1)

•	CPEX PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events
	EDGAR Online (Wed, Jan 27)

•	CPEX PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events
	EDGAR Online (Fri, Jan 8)

•	CPEX Pharmaceuticals Reports on SEC Filing by Arcadia Capital Advisors
	Business Wire (Fri, Jan 8)

•	Loews Co-Chairman Tisch Sells $16.6M Worth
	at TheStreet.com (Thu, Dec 31)

•	CPEX Pharmaceuticals Announces Completion of Enrollment in Phase 2a Clinical Trial of Nasulin
	Business Wire (Mon, Dec 21)

•	CPEX PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report
	EDGAR Online (Thu, Nov 12)

•	CPEX PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition
	EDGAR Online (Wed, Nov 4)

More Headlines for CPEX...

ANALYST

EPS Est (next year) (Dec-09) :	N/A
EPS Est (in 2 years) (Dec-10) :	N/A
Avg Rec (current)*:	2.0
PEG Ratio:	N/A

* (Strong Buy) 1.0 - 5.0 (Strong Sell)

Analyst Opinion - Estimates

BUSINESS SUMMARY

CPEX Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development, licensing, and commercialization of pharmaceutical products utilizing its validated drug delivery technology.

Full Company Profile

Add to Portfolio

Email to a Friend

•